A Dissection Method to Harvest Murine Popliteal Draining Lymph Nodes for Ex Vivo Imaging

Executive Industry Relevance

Isolating intact murine lymph nodes with preserved structure and viability enables precise ex vivo imaging of immune cell interactions, supporting mechanistic de-risking in immunology target validation. This method provides a reproducible system for studying lymphatic function in preclinical models, enhancing predictive confidence in early discovery workflows. By maintaining tissue integrity, it facilitates downstream assays that inform go/no-go decisions in immunotherapy development pipelines.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses by preserving lymph node architecture for immune cell localization studies.
• Operational Value: Provides a standardized dissection technique to obtain viable lymphoid tissue for functional target validation.
• Predictive Value: Supports biological de-risking through direct visualization of immune responses in a disease-relevant system.

Screening & Assay Development

• Scientific Value: Prepares lymph nodes for quantitative ex vivo imaging assays that measure cellular localization and structural changes.
• Operational Value: Ensures tissue hydration and viability via buffer-soaked sheets, improving assay reproducibility and readiness.
• Scalability: Uses microsurgery forceps and mineral oil preparation to enable consistent tissue harvesting across experimental cohorts.

Translational & Preclinical Research

• Translational Continuity: Maintains lymph node integrity from harvest to imaging, supporting preclinical validation of immunomodulatory mechanisms.
• Mechanistic De-risking: Allows observation of innate-adaptive immune bridging in a controlled ex vivo setting, reducing ambiguity in target engagement.
• Preclinical Model Relevance: Focuses on the popliteal draining lymph node as a hind leg-specific model for studying localized immune responses.

Pipeline & Workflow Integration

This dissection method fits within the discovery continuum by providing a reliable tissue preparation step between animal model use and downstream analytical imaging, enabling consistent handoff to fluorescence or confocal microscopy workflows.

• Discovery Biology: Supports hypothesis testing by isolating lymph nodes that reflect physiological immune cell trafficking and localization.
• Screening: Delivers standardized, viable lymphoid tissue suitable for high-resolution imaging assays requiring structural preservation.
• Analytics: Enables quantitative readouts on cellular distribution and tissue architecture critical for comparing experimental conditions.
• Translational Research: Connects in vivo immune responses to ex vivo validation through preserved tissue viability and architecture.
• Enterprise Reuse: Establishes a reusable dissection protocol for lymph node harvesting across multiple immunology studies and model systems.

Operational & Enterprise Impact

• Scientific Value: Enhances target validation confidence by reducing mechanistic ambiguity in immune response studies.
• Operational Value: Promotes standardization and reproducibility in lymph node preparation across laboratories and experiments.
• Strategic Value: Improves go/no-go decision-making in immunotherapy development by providing reliable preclinical immune response data.
• Portfolio Impact: Enables risk-adjusted prioritization of immunomodulatory candidates based on validated lymphatic target engagement.

Implementation Considerations

• Requires expertise in murine dissection and microsurgery techniques for precise tissue isolation.
• Dependent on instrumentation such as curved forceps and microscopy-compatible culture dishes.
• Necessitates standardization of mineral oil application and buffer solution use across teams.
• Involves adaptation considerations when applying the technique to other lymphoid tissues or disease models.
• Limited by the need for immediate post-harvest processing to maintain tissue viability for imaging assays.

Biopharma FAQs